RT Book, Section A1 Wright, Chanin C. A1 Vera, Yolanda Y. A2 DiPiro, Joseph T. A2 Talbert, Robert L. A2 Yee, Gary C. A2 Matzke, Gary R. A2 Wells, Barbara G. A2 Posey, L. Michael SR Print(0) ID 1145180671 T1 Cystic Fibrosis T2 Pharmacotherapy: A Pathophysiologic Approach, 10e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259587481 LK accesspharmacy.mhmedical.com/content.aspx?aid=1145180671 RD 2024/03/29 AB KEY CONCEPTS Good nutrition with appropriate pancreatic enzyme and vitamin supplementation are essential in the management of cystic fibrosis (CF). Airway clearance and anti-inflammatory therapies are key components to improve pulmonary health in CF patients. Antipseudomonal agents are the cornerstone of antibiotic therapy for chronic lung infections in the CF patient. Altered pharmacokinetics of CF patients can impact the dosing and clearance of pharmacologic therapy.